Global cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2015 | 20.7K |
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | International Journal of Cancer | 2015 | 19.3K |
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Genetics in Medicine | 2015 | 12K |
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | Systematic Reviews | 2015 | 10.8K |
Cancer statistics, 2015 | Ca-A Cancer Journal for Clinicians | 2015 | 10.2K |
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging | Journal of the American Society of Echocardiography | 2015 | 6.1K |
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes | New England Journal of Medicine | 2015 | 6.1K |
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer | New England Journal of Medicine | 2015 | 6K |
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | New England Journal of Medicine | 2015 | 5.6K |
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer | New England Journal of Medicine | 2015 | 5.5K |
Heart disease and stroke statistics--2015 update: a report from the American Heart Association | Circulation | 2015 | 5.3K |
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | New England Journal of Medicine | 2015 | 5K |
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Lancet, The | 2015 | 4.6K |
Second-generation PLINK: rising to the challenge of larger and richer datasets | GigaScience | 2015 | 4.2K |
A randomized trial of intraarterial treatment for acute ischemic stroke | New England Journal of Medicine | 2015 | 4.1K |
Pembrolizumab for the treatment of non-small-cell lung cancer | New England Journal of Medicine | 2015 | 3.9K |
Predicting effective microRNA target sites in mammalian mRNAs | ELife | 2015 | 3.8K |
Nivolumab in previously untreated melanoma without BRAF mutation | New England Journal of Medicine | 2015 | 3.8K |
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Lancet, The | 2015 | 3.8K |
Pembrolizumab versus Ipilimumab in Advanced Melanoma | New England Journal of Medicine | 2015 | 3.8K |
Randomized assessment of rapid endovascular treatment of ischemic stroke | New England Journal of Medicine | 2015 | 3.8K |
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma | New England Journal of Medicine | 2015 | 3.7K |
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging | European Heart Journal Cardiovascular Imaging | 2015 | 3.6K |
Endovascular therapy for ischemic stroke with perfusion-imaging selection | New England Journal of Medicine | 2015 | 3.6K |
CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes | Genome Research | 2015 | 3.4K |